Christiansen, Sara NysomHorskjær Rasmussen, SimonØstergaard, MikkelPons, MarionMichelsen, BrigittePavelka, KarelCodreanu, CatalinCiurea, AdrianGlintborg, BenteSantos, Maria JoseSari, IsmailRotar, ZigaGudbjornsson, BjornMacfarlane, GaryRelas, HeikkiIannone, FlorenzoLaas, KarinWallman, Johan KVan de Sande, Marleen G.H.Provan, Sella AarrestadCastrejon, IsabelZavada, JakubMogosan, CorinaNissen, Michael JLoft, Anne GitteBarcelos, AnabelaErez, YesimPirkmajer, Katja PerdanGrondal, GerdurJones, GarethHokkanen, Anna-MariChimenti, Maria SoleVorobjov, SigridDi Giuseppe, DanielaKvien, Tore KOtero-Varela, Luciavan der Horst-Bruinsma, Irene EHetland, Merete LundMidtbøll Ørnbjerg, Lykke2024-10-212024-10-212024-07-24Christiansen, S N, Horskjær Rasmussen, S, Østergaard, M, Pons, M, Michelsen, B, Pavelka, K, Codreanu, C, Ciurea, A, Glintborg, B, Santos, M J, Sari, I, Rotar, Z, Gudbjornsson, B, Macfarlane, G, Relas, H, Iannone, F, Laas, K, Wallman, J K, Van de Sande, M G H, Provan, S A, Castrejon, I, Zavada, J, Mogosan, C, Nissen, M J, Loft, A G, Barcelos, A, Erez, Y, Pirkmajer, K P, Grondal, G, Jones, G, Hokkanen, A-M, Chimenti, M S, Vorobjov, S, Di Giuseppe, D, Kvien, T K, Otero-Varela, L, van der Horst-Bruinsma, I E, Hetland, M L & Midtbøll Ørnbjerg, L 2024, 'Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis : a European routine-care observational study', RMD Open, vol. 10, no. 3, e00416. https://doi.org/10.1136/rmdopen-2024-0041662056-5933ORCID: /0000-0003-0016-7591/work/170010484ORCID: /0000-0003-2322-3314/work/170011040https://hdl.handle.net/2164/24442Novartis Pharma AG for supporting the EuroSpA collaboration. The paper has been presented at the Scandinavia Congress of Rheumatology 2023 as an oral presentation and at the EULAR 2023 Congress as a poster presentation (POS0656) with the following abstract: SNC, SHR, LMO, etc. Does radiographic status impact secukinumab effectiveness in European axial spondyloarthritis patients treated in routine care? Annals of the Rheumatic Diseases 2023;82:606-607.131595453engR MedicineSupplementary Datahttps://rmdopen.bmj.com/highwire/filestream/147723/field_highwire_adjunct_files/1/rmdopen-2024-004166supp002_data_supplement.pdfhttps://rmdopen.bmj.com/highwire/filestream/147723/field_highwire_adjunct_files/0/rmdopen-2024-004166supp001_data_supplement.pdfhttps://rmdopen.bmj.com/highwire/filestream/147723/field_highwire_adjunct_files/2/rmdopen-2024-004166supp003_data_supplement.pdfSupplementary Informationhttps://rmdopen.bmj.com/content/rmdopen/10/3/e004166/DC3/embed/inline-supplementary-material-3.pdf?download=trueRJournal article10.1136/rmdopen-2024-004166http://www.scopus.com/inward/record.url?scp=85199661747&partnerID=8YFLogxK103